During the second and third year, the fellows will primarily focus on their research and quality improvement projects. By the end of the first year, they are expected to have identified their research project and mentor. Funding for two years of research is guaranteed to all accepted fellows.
The Division of Endocrinology offers the opportunity for research in many areas of endocrinology. Andrew Dauber, M.D., Chief of Endocrinology, work focuses on novel etiologies of short stature, and he leads a multi-center study integrating genomics with electronic health records to identify patients with undiagnosed genetic growth disorders. Dr. Dauber is also leading innovative clinical trials of novel therapeutics for genetic conditions causing short stature. Eric Vilain, M.D., the director of the Center for Genetic Medicine Research, leads a national network of researchers exploring the genetic basis of disorders of sexual differentiation. Maureen Monaghan, M.D., and Randi Streisand, M.D. are conducting multiple studies using behavioral interventions to improve diabetes care. Brynn Marks, M.D., is leading multiple studies examining the use of diabetes technologies in children with type 1 diabetes. Additional active areas of research include type 2 diabetes, bone health, diabetes technology and Turner syndrome. Additionally, fellows will be given the opportunity to work on research projects with mentors throughout the institution as well as in the pediatric endocrinology program at the NIH.
Fellows will be required to present their work at national meetings and submit a manuscript prior to the end of the fellowship.
Fellows will work on the inpatient service for six weeks per year in their second and third year and be part of the night float. They will continue to do one half-day continuity clinic every week and may substitute one to two of their clinics per month with specialty clinics of their choice.